Lyuba Azbel1, Jeffrey A Wickersham1, Martin P Wegman1, Maxim Polonsky1, Murad Suleymanov2, Rafik Ismayilov3, Sergey Dvoryak4, Signe Rotberga5, Frederick L Altice6. 1. Yale University School of Medicine, Section of Infectious Diseases, New Haven, CT, USA. 2. Main Medical Department of the Ministry of Justice of the Azerbaijan Republic, Baku, Azerbaijan. 3. Independent Assistance and Consultancy Center "For the Sake of Civil Society", Baku, Azerbaijan. 4. Ukrainian Institute on Public Health Policy, Kiev, Ukraine. 5. Head of UNODC Program Office in Kazakhstan, Astana, Kazakhstan. 6. Yale University School of Medicine, Section of Infectious Diseases, New Haven, CT, USA; Yale University School of Public Health, Division of Epidemiology of Microbial Diseases, New Haven, CT, USA. Electronic address: lyuba.azbel@yale.edu.
Abstract
BACKGROUND: Despite low HIV prevalence in the South Caucasus region, transmission is volatile. Little data are available from this region about addiction and infectious diseases among prisoners who transition back to communities. METHODS: A nation-wide randomly sampled biobehavioral health survey was conducted in 13 non-specialty Azerbaijani prisons among soon-to-be-released prisoners. After informed consent, participants underwent standardized health assessment surveys and testing for HIV, hepatitis B and C, and syphilis. RESULTS: Of the 510 participants (mean age = 38.2 years), 11.4% were female, and 31.9% reported pre-incarceration drug injection, primarily of heroin. Prevalence of HCV (38.2%), HIV (3.7%), syphilis (3.7%), and HBV (2.7%) was high. Among the 19 HIV-infected inmates, 14 (73.7%) were aware of their HIV status, 12 (63.2%) were receiving antiretroviral therapy (ART), and 5 (26.3%) had CD4 < 350 cells/mL (4 of these were on ART). While drug injection was the most significant independent correlate of HCV (AOR = 12.9; p = 0.001) and a significant correlate of HIV (AOR = 8.2; p = 0.001), both unprotected sex (AOR = 3.31; p = 0.049) and working in Russia/Ukraine (AOR = 4.58; p = 0.008) were also correlated with HIV. CONCLUSION: HIV and HCV epidemics are concentrated among people who inject drugs (PWIDs) in Azerbaijan, and magnified among prisoners. A transitioning HIV epidemic is emerging from migration from high endemic countries and heterosexual risk. The high diagnostic rate and ART coverage among Azerbaijani prisoners provides new evidence that HIV treatment as prevention in former Soviet Union (FSU) countries is attainable, and provides new insights for HCV diagnosis and treatment as new medications become available. Within prison evidence-based addiction treatments with linkage to community care are urgently needed.
BACKGROUND: Despite low HIV prevalence in the South Caucasus region, transmission is volatile. Little data are available from this region about addiction and infectious diseases among prisoners who transition back to communities. METHODS: A nation-wide randomly sampled biobehavioral health survey was conducted in 13 non-specialty Azerbaijani prisons among soon-to-be-released prisoners. After informed consent, participants underwent standardized health assessment surveys and testing for HIV, hepatitis B and C, and syphilis. RESULTS: Of the 510 participants (mean age = 38.2 years), 11.4% were female, and 31.9% reported pre-incarceration drug injection, primarily of heroin. Prevalence of HCV (38.2%), HIV (3.7%), syphilis (3.7%), and HBV (2.7%) was high. Among the 19 HIV-infected inmates, 14 (73.7%) were aware of their HIV status, 12 (63.2%) were receiving antiretroviral therapy (ART), and 5 (26.3%) had CD4 < 350 cells/mL (4 of these were on ART). While drug injection was the most significant independent correlate of HCV (AOR = 12.9; p = 0.001) and a significant correlate of HIV (AOR = 8.2; p = 0.001), both unprotected sex (AOR = 3.31; p = 0.049) and working in Russia/Ukraine (AOR = 4.58; p = 0.008) were also correlated with HIV. CONCLUSION: HIV and HCV epidemics are concentrated among people who inject drugs (PWIDs) in Azerbaijan, and magnified among prisoners. A transitioning HIV epidemic is emerging from migration from high endemic countries and heterosexual risk. The high diagnostic rate and ART coverage among Azerbaijani prisoners provides new evidence that HIV treatment as prevention in former Soviet Union (FSU) countries is attainable, and provides new insights for HCV diagnosis and treatment as new medications become available. Within prison evidence-based addiction treatments with linkage to community care are urgently needed.
Authors: Timothy P Flanigan; Nickolas Zaller; Curt G Beckwith; Lauri B Bazerman; Aadia Rana; Adrian Gardner; David A Wohl; Frederick L Altice Journal: J Acquir Immune Defic Syndr Date: 2010-12 Impact factor: 3.731
Authors: Maxim Polonsky; Julia Rozanova; Lyuba Azbel; Chethan Bachireddy; Jacob Izenberg; Tetiana Kiriazova; Sergii Dvoryak; Frederick L Altice Journal: AIDS Behav Date: 2016-12
Authors: Julia Rozanova; Olga Morozova; Lyuba Azbel; Chethan Bachireddy; Jacob M Izenberg; Tetiana Kiriazova; Sergiy Dvoryak; Frederick L Altice Journal: J Urban Health Date: 2018-08 Impact factor: 3.671
Authors: Lyuba Azbel; Maxim Polonsky; Martin Wegman; Natalya Shumskaya; Ainura Kurmanalieva; Akylbek Asanov; Jeffrey A Wickersham; Sergii Dvoriak; Frederick L Altice Journal: Int J Drug Policy Date: 2016-06-11
Authors: Josiah D Rich; Curt G Beckwith; Alexandria Macmadu; Brandon D L Marshall; Lauren Brinkley-Rubinstein; Joseph J Amon; M-J Milloy; Maximilian R F King; Jorge Sanchez; Lukoye Atwoli; Frederick L Altice Journal: Lancet Date: 2016-07-14 Impact factor: 79.321
Authors: Lyuba Azbel; Martin P Wegman; Maxim Polonsky; Chethan Bachireddy; Jaimie Meyer; Natalya Shumskaya; Ainura Kurmanalieva; Sergey Dvoryak; Frederick L Altice Journal: Int J Prison Health Date: 2018-09-10
Authors: Frederick L Altice; Lyuba Azbel; Jack Stone; Ellen Brooks-Pollock; Pavlo Smyrnov; Sergii Dvoriak; Faye S Taxman; Nabila El-Bassel; Natasha K Martin; Robert Booth; Heino Stöver; Kate Dolan; Peter Vickerman Journal: Lancet Date: 2016-07-14 Impact factor: 79.321
Authors: Phillip L Marotta; Assel Terlikbayeva; Louisa Gilbert; Alissa Davis; Elwin Wu; Lisa Metsch; Dan Feaster; Nabila El-Bassel Journal: Int J Drug Policy Date: 2020-10-21